| Value | ₹1.02 Cr |
|---|
BSE filing, NSE: NIMBSPROJ. Summary written from the filing by ALFA Finder's alert engine.
Nimbus Projects Ltd: key numbers
- Share price
- ₹178.00
- Market cap
- ₹343.9 Cr
- Revenue (annual)
- ₹228.8 Cr
- Net profit (annual)
- ₹-68.20 Cr
- P/E (TTM)
- -8.6×Sector 35.9×
- Promoter holding
- 70.46%-0.04% QoQ
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nimbus Projects Ltd
All →Nimbus Projects Board Meeting Date
Nimbus Projects Ltd announced a board meeting for November 5, 2026, to approve Q1 and H1 FY27 results. No financial figures have been disclosed yet.
Nimbus Projects Promoter Reclassification
Nimbus Projects reclassified four individuals from the Promoter category to the Public category, following approval from BSE and NSE. The promoter count reduced from 18 to 14.
Nimbus Projects Acquisition Worth ₹1.02 Cr
Nimbus Projects incorporated its subsidiary, IITL Nimbus The Express Park View Private Limited. The company acquired a 95% stake by converting its Rs.1.02 Crore capital contribution.
- Value
- ₹1.02 Cr
Nimbus Projects Acquisition Worth ₹0.25 Cr
Nimbus Projects Limited incorporated a subsidiary, IITL Nimbus The Hyde Park Private Limited, by converting its ₹0.25 Crore capital contribution in a partnership firm.
- Value
- ₹0.25 Cr
Nimbus Projects Capacity Expansion: ₹15 Cr Investment
Nimbus Projects Limited entered a strategic investment agreement with Sankalp Agencies Private Limited to invest ₹15.00 Crore in a commercial real estate project in New Delhi.
- Value
- ₹15.00 Cr
- From
- Sankalp Agencies Private Limited
- commercial land area
- 6252.6 sq. m.
Nimbus Projects Debt & Borrowing: ₹30 Cr
Nimbus Projects Ltd's board approved availing an unsecured loan of ₹30 Crore from World Resorts Limited. The facility carries an interest rate of 12% per annum.
- Value
- ₹30.00 Cr
- From
- World Resorts Limited
- Execution
- 2 years
Other merger & restructuring announcements
All →Fermenta Biotech Merger & Restructuring
Fermenta Biotech Limited's board has approved the closure of its inactive wholly-owned subsidiary, Fermenta Biotech (UK) Limited. The move aims to reorganize corporate structure and reduce compliance costs following the UK's exit from the EU.
Thomas Cook (India) Merger & Restructuring
Thomas Cook (India) Ltd announced that the NCLT Mumbai Bench has issued directions regarding its composite scheme of arrangement. The scheme involves demergers and amalgamations with Sterling Holiday Resorts and other group entities.
Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days